{"altmetric_id":5625997,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"total":{"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[58801],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa60b3cf058f610006a71","authors":["Gellad ZF","Reed SD","Muir AJ","Ziad F Gellad","Shelby D Reed","Andrew J Muir"],"doi":"10.3851\/imp2430","endpage":"1199","first_seen_on":"2016-02-17T20:38:48+00:00","issns":["1359-6535","13596535"],"issue":"6 Pt B","journal":"Antiviral Therapy","last_mentioned_on":1455627600,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23186646"],"pmid":"23186646","pubdate":"2012-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Microbiology","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"},{"name":"Medical Microbiology","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"1189","subjects":["drugtherapy"],"title":"Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C","type":"article","uri":"http:\/\/www.intmedpress.com\/journals\/avt\/abstract.cfm?id=2430&pid=88","volume":"17","mendeley_url":"http:\/\/www.mendeley.com\/research\/economic-evaluation-directacting-antiviral-therapy-chronic-hepatitis-c"},"altmetric_score":{"score":5.08,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.08},"context_for_score":{"all":{"total_number_of_other_articles":7200541,"mean":6.3358503237224,"rank":1271243,"this_scored_higher_than_pct":82,"this_scored_higher_than":5914476,"rank_type":"exact","sample_size":7200541,"percentile":82},"similar_age_3m":{"total_number_of_other_articles":283628,"mean":10.288945248513,"rank":66527,"this_scored_higher_than_pct":76,"this_scored_higher_than":216519,"rank_type":"exact","sample_size":283628,"percentile":76},"this_journal":{"total_number_of_other_articles":246,"mean":2.096106122449,"rank":17,"this_scored_higher_than_pct":93,"this_scored_higher_than":229,"rank_type":"exact","sample_size":246,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":5,"mean":0.7125,"rank":1,"this_scored_higher_than_pct":80,"this_scored_higher_than":4,"rank_type":"exact","sample_size":5,"percentile":80}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":4,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":6,"Student  > Postgraduate":1,"Student  > Master":5,"Other":3,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":9,"Social Sciences":1,"Economics, Econometrics and Finance":2,"Agricultural and Biological Sciences":6,"Business, Management and Accounting":3,"Biochemistry, Genetics and Molecular Biology":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"US":1,"ES":1}}},"posts":{"blogs":[{"title":"Should We Take Chlorella to Boost Natural Killer Cell Activity?","url":"http:\/\/nutritionfacts.org\/2016\/02\/16\/should-we-take-chlorella-to-boost-natural-killer-cell-activity\/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=should-we-take-chlorella-to-boost-natural-killer-cell-activity","license":"public","citation_ids":[1642980,5625994,5625995,2949921,866751,5625996,5625997,1646908,1935536],"posted_on":"2016-02-16T13:00:00+00:00","summary":"Multiple studies published over the last few decades suggest that exercise can mitigate the decline in immune function as we age. Exercising can boost the activity of natural killer cells, our immune soldiers that focus on eliminating both tumor cells and","author":{"name":"NutritionFacts.org","url":"http:\/\/nutritionfacts.org\/","description":"The Latest in Nutrition Research"}}]}}